Blood protein may predict Life-Threatening placental disorder
NCT ID NCT07421180
First seen Feb 21, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study looked at whether a protein called adropin in the blood can help identify placenta accreta spectrum (PAS), a condition where the placenta grows too deeply into the uterine wall. Researchers compared 42 pregnant women with PAS or placenta previa to 42 healthy pregnant women. They measured adropin levels before delivery to see if it could predict PAS. The goal is to find a simple blood test to detect this serious condition earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLACENTA PREVIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Heath and Science Adana City Hospital
Adana, Yuregir, 01100, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.